Circassia Pharmaceuticals (GB:NIOX) has released an update.
Circassia Pharmaceuticals has announced a significant change in its shareholder structure, with Richard Griffiths and controlled undertakings crossing a notable threshold on July 12, 2024, resulting in a new total voting rights position of 15.97%. This reflects a decrease from the previous notification where they held 18.98% of the voting rights. The detailed notification reveals the distribution of voting rights among various controlled entities, including Ora Global Limited and Sarossa Plc.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
